# COVID-19: Clinical Research Products Development Center (CRPMC)

> **NIH NIH N01** · FISHER BIOSERVICES, INC. · 2020 · $1,196,744

## Abstract

NIAID has a requirement for the management and operation of a Clinical Research Products Management Center (CRPMC) to support NIAID-sponsored clinical research trials both domestically and internationally. This contract will provide pharmaceutical services and study product management by providing a cGMP-compliant facility, receipt, storage, labeling, packaging, repackaging, shipping, acquiring, and disposition of study products. This contract will provide cognitive pharmaceutical services including evaluating draft protocols; reviewing site pharmacy monitoring reports and maintaining a site audit pharmacy report database; providing study product storage and stability information, guidance in research pharmacy practice and study product management activities to clinical site pharmacists; and conducting Current Good Manufacturing Practice (cGMP) audits of manufacturing facilities.  This project will support study product management and distribution of the study products for COVID-19 clinical trial A5401 (ACTIV-2 Outpatient Monoclonal Antibodies And Other Therapies).

## Key facts

- **NIH application ID:** 10244841
- **Project number:** 75N93020C00032-0-9999-2
- **Recipient organization:** FISHER BIOSERVICES, INC.
- **Principal Investigator:** NEERAJA PUTTA
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $1,196,744
- **Award type:** —
- **Project period:** 2020-06-16 → 2021-06-15

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10244841

## Citation

> US National Institutes of Health, RePORTER application 10244841, COVID-19: Clinical Research Products Development Center (CRPMC) (75N93020C00032-0-9999-2). Retrieved via AI Analytics 2026-05-21 from https://api.ai-analytics.org/grant/nih/10244841. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*